FDA Proposes Overhaul of Fast-Track Process for Cancer Meds

March 28, 2023

(Axios) – The Food and Drug Administration is eyeing policy changes that could make drugmakers conduct more stringent trials to win fast-track approvals of cancer drugs. Why it matters: The agency’s accelerated approval process has drawn fire for the way it allows manufacturers to launch products based on preliminary evidence and charge high prices before they complete trials. (Read More)